| pubmed-article:12671699 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12671699 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:12671699 | lifeskim:mentions | umls-concept:C0678222 | lld:lifeskim |
| pubmed-article:12671699 | lifeskim:mentions | umls-concept:C1512492 | lld:lifeskim |
| pubmed-article:12671699 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:12671699 | pubmed:dateCreated | 2003-4-2 | lld:pubmed |
| pubmed-article:12671699 | pubmed:abstractText | Examination of parity, age at menarche and at menopause by HER2 status in a large series of breast carcinomas showed a statistically significant increased-frequency of HER2-positive tumours in lower risk subgroups. The findings suggest a difference in the protective role of hormone-related risk factors between HER2-positive and -negative tumours. | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12671699 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12671699 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12671699 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12671699 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:12671699 | pubmed:issn | 0007-0920 | lld:pubmed |
| pubmed-article:12671699 | pubmed:author | pubmed-author:MénardSS | lld:pubmed |
| pubmed-article:12671699 | pubmed:author | pubmed-author:BalsariAA | lld:pubmed |
| pubmed-article:12671699 | pubmed:author | pubmed-author:BerrinoFF | lld:pubmed |
| pubmed-article:12671699 | pubmed:author | pubmed-author:BufalinoRR | lld:pubmed |
| pubmed-article:12671699 | pubmed:author | pubmed-author:CasaliniPP | lld:pubmed |
| pubmed-article:12671699 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12671699 | pubmed:day | 7 | lld:pubmed |
| pubmed-article:12671699 | pubmed:volume | 88 | lld:pubmed |
| pubmed-article:12671699 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12671699 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12671699 | pubmed:pagination | 1032-4 | lld:pubmed |
| pubmed-article:12671699 | pubmed:dateRevised | 2010-9-14 | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:meshHeading | pubmed-meshheading:12671699... | lld:pubmed |
| pubmed-article:12671699 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12671699 | pubmed:articleTitle | Role of hormonal risk factors in HER2-positive breast carcinomas. | lld:pubmed |
| pubmed-article:12671699 | pubmed:affiliation | Istituto Nazionale Tumori, Milano, Italy. | lld:pubmed |
| pubmed-article:12671699 | pubmed:publicationType | Journal Article | lld:pubmed |
